|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 5, 3447-3454, January 30, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Howard Hughes Medical Institute, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts 02215
Ser/Thr phosphorylation of insulin receptor substrate IRS-1 regulates insulin signaling, but the relevant phosphorylated residues and their potential functions during insulin-stimulated signal transduction are difficult to resolve. We used a sequence-specific polyclonal antibody directed against phosphorylated Ser302 to study IRS-1-mediated signaling during insulin and insulin-like growth factor IGF-I stimulation. Insulin or IGF-I stimulated phosphorylation of Ser302 in various cell backgrounds and in murine muscle. Wortmannin or rapamycin inhibited Ser302 phosphorylation, and amino acids or glucose stimulated Ser302 phosphorylation, suggesting a role for the mTOR cascade. The Ser302 kinase associates with IRS-1 during immunoprecipitation, but its identity is unknown. The NH2-terminal c-Jun kinase did not phosphorylate Ser302. Replacing Ser302 with alanine significantly reduced insulin-stimulated tyrosine phosphorylation of IRS-1 and p85 binding and reduced insulin-stimulated phosphorylation of p70S6K, ribosomal S6 protein, and 4E-BP1; however, this mutation had no effect on insulin-stimulated Akt or glycogen synthase kinase 3
phosphorylation. Replacing Ser302 with alanine reduced insulin/IGF-I-stimulated DNA synthesis. We conclude that Ser302 phosphorylation integrates nutrient availability with insulin/IGF-I signaling to promote mitogenesis and cell growth.
Received for publication, August 5, 2003 , and in revised form, October 9, 2003.
* This work was supported in part by National Institutes of Health Grant DK 38712. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Molecular Physiology, Joslin Diabetes Center, One Joslin Place, Rm. 620, Boston, MA 02215. Tel.: 617-732-2578; Fax: 617-732-2593; E-mail: morris.white{at}joslin.harvard.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Algire, M. Zakikhani, M.-J. Blouin, J. H. Shuai, and M. Pollak Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth Endocr. Relat. Cancer, September 1, 2008; 15(3): 833 - 839. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Lee, E. G. Lynn, J.-a Kim, and M. J. Quon Protein Kinase C-{zeta} Phosphorylates Insulin Receptor Substrate-1, -3, and -4 But Not -2: Isoform Specific Determinants of Specificity in Insulin Signaling Endocrinology, May 1, 2008; 149(5): 2451 - 2458. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pflieger, M. A. Junger, M. Muller, O. Rinner, H. Lee, P. M. Gehrig, M. Gstaiger, and R. Aebersold Quantitative Proteomic Analysis of Protein Complexes: Concurrent Identification of Interactors and Their State of Phosphorylation Mol. Cell. Proteomics, February 1, 2008; 7(2): 326 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Kim, J. E. Kim, H.-Y. Liu, W. Cao, and J. Chen Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway J. Biol. Chem., January 11, 2008; 283(2): 708 - 715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ost, A. Danielsson, M. Liden, U. Eriksson, F. H. Nystrom, and P. Stralfors Retinol-binding protein-4 attenuates insulin-induced phosphorylation of IRS1 and ERK1/2 in primary human adipocytes FASEB J, November 1, 2007; 21(13): 3696 - 3704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Giraud, M. Haas, E. P. Feener, K. D. Copps, X. Dong, S. L. Dunn, and M. F. White Phosphorylation of Irs1 at SER-522 Inhibits Insulin Signaling Mol. Endocrinol., September 1, 2007; 21(9): 2294 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wang, X. Mao, L. Wang, M. Liu, M. D. Wetzel, K.-L. Guan, L. Q. Dong, and F. Liu Adiponectin Sensitizes Insulin Signaling by Reducing p70 S6 Kinase-mediated Serine Phosphorylation of IRS-1 J. Biol. Chem., March 16, 2007; 282(11): 7991 - 7996. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morino, K. F. Petersen, and G. I. Shulman Molecular Mechanisms of Insulin Resistance in Humans and Their Potential Links With Mitochondrial Dysfunction Diabetes, December 1, 2006; 55(Supplement_2): S9 - S15. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Panasyuk, I. Nemazanyy, A. Zhyvoloup, M. Bretner, D. W. Litchfield, V. Filonenko, and I. T. Gout Nuclear Export of S6K1 II Is Regulated by Protein Kinase CK2 Phosphorylation at Ser-17 J. Biol. Chem., October 20, 2006; 281(42): 31188 - 31201. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Shah and T. Hunter Turnover of the Active Fraction of IRS1 Involves Raptor-mTOR- and S6K1-Dependent Serine Phosphorylation in Cell Culture Models of Tuberous Sclerosis. Mol. Cell. Biol., September 1, 2006; 26(17): 6425 - 6434. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Choi, J. S. Jang, S. M. Hong, D. W. Jun, and S. Park Exercise and dexamethasone oppositely modulate {beta}-cell function and survival via independent pathways in 90% pancreatectomized rats. J. Endocrinol., August 1, 2006; 190(2): 471 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Hennige, N. Stefan, K. Kapp, R. Lehmann, C. Weigert, A. Beck, K. Moeschel, J. Mushack, E. Schleicher, and H.-U. Haring Leptin down-regulates insulin action through phosphorylation of serine-318 in insulin receptor substrate 1 FASEB J, June 1, 2006; 20(8): 1206 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weigert, A. M. Hennige, R. Lehmann, K. Brodbeck, F. Baumgartner, M. Schauble, H. U. Haring, and E. D. Schleicher Direct Cross-talk of Interleukin-6 and Insulin Signal Transduction via Insulin Receptor Substrate-1 in Skeletal Muscle Cells J. Biol. Chem., March 17, 2006; 281(11): 7060 - 7067. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bouzakri, H. K.R. Karlsson, H. Vestergaard, S. Madsbad, E. Christiansen, and J. R. Zierath IRS-1 Serine Phosphorylation and Insulin Resistance in Skeletal Muscle From Pancreas Transplant Recipients Diabetes, March 1, 2006; 55(3): 785 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Weigert, A. M. Hennige, T. Brischmann, A. Beck, K. Moeschel, M. Schauble, K. Brodbeck, H.-U. Haring, E. D. Schleicher, and R. Lehmann The Phosphorylation of Ser318 of Insulin Receptor Substrate 1 Is Not per se Inhibitory in Skeletal Muscle Cells but Is Necessary to Trigger the Attenuation of the Insulin-stimulated Signal J. Biol. Chem., November 11, 2005; 280(45): 37393 - 37399. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Danielsson, A. Ost, F. H. Nystrom, and P. Stralfors Attenuation of Insulin-stimulated Insulin Receptor Substrate-1 Serine 307 Phosphorylation in Insulin Resistance of Type 2 Diabetes J. Biol. Chem., October 14, 2005; 280(41): 34389 - 34392. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Taniyama, H. Hitomi, A. Shah, R. W. Alexander, and K. K. Griendling Mechanisms of Reactive Oxygen Species-Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1142 - 1147. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Schattenberg, Y. Wang, R. Singh, R. M. Rigoli, and M. J. Czaja Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling J. Biol. Chem., March 18, 2005; 280(11): 9887 - 9894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liberman and H. Eldar-Finkelman Serine 332 Phosphorylation of Insulin Receptor Substrate-1 by Glycogen Synthase Kinase-3 Attenuates Insulin Signaling J. Biol. Chem., February 11, 2005; 280(6): 4422 - 4428. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Manning Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis J. Cell Biol., November 8, 2004; 167(3): 399 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Mihindukulasuriya, G. Zhou, J. Qin, and T.-H. Tan Protein Phosphatase 4 Interacts with and Down-regulates Insulin Receptor Substrate 4 following Tumor Necrosis Factor-{alpha} Stimulation J. Biol. Chem., November 5, 2004; 279(45): 46588 - 46594. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Werner, J. Lee, L. Hansen, M. Yuan, and S. E. Shoelson Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302 J. Biol. Chem., August 20, 2004; 279(34): 35298 - 35305. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Harrington, G. M. Findlay, A. Gray, T. Tolkacheva, S. Wigfield, H. Rebholz, J. Barnett, N. R. Leslie, S. Cheng, P. R. Shepherd, et al. The TSC1-2 tumor suppressor controls insulin-PI3K signaling via regulation of IRS proteins J. Cell Biol., July 19, 2004; 166(2): 213 - 223. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |